Guggenheim Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.4M | Sell |
37,348
-2,981
| -7% | -$1.62M | 0.14% | 144 |
|
|
2025
Q4 | $23.4M | Sell |
40,329
-2,655
| -6% | -$1.5M | 0.17% | 115 |
|
|
2025
Q3 | $20.8M | Sell |
42,984
-270
| -0.6% | -$126K | 0.15% | 127 |
|
|
2025
Q2 | $17.5M | Buy |
43,254
+792
| +2% | +$331K | 0.14% | 141 |
|
|
2025
Q1 | $21.1M | Buy |
42,462
+1,841
| +5% | +$997K | 0.19% | 103 |
|
|
2024
Q4 | $21.1M | Buy |
40,621
+2,328
| +6% | +$1.28M | 0.17% | 111 |
|
|
2024
Q3 | $23.7M | Buy |
38,293
+1,136
| +3% | +$672K | 0.17% | 117 |
|
|
2024
Q2 | $20.5M | Sell |
37,157
-298
| -0.8% | -$171K | 0.15% | 136 |
|
|
2024
Q1 | $21.8M | Buy |
37,455
+144
| +0.4% | +$80.8K | 0.15% | 129 |
|
|
2023
Q4 | $19.8M | Buy |
37,311
+2,242
| +6% | +$1.09M | 0.15% | 134 |
|
|
2023
Q3 | $17.8M | Sell |
35,069
-2,053
| -6% | -$1.09M | 0.15% | 136 |
|
|
2023
Q2 | $19.4M | Buy |
37,122
+3,847
| +12% | +$2.08M | 0.15% | 131 |
|
|
2023
Q1 | $19.2M | Buy |
33,275
+6,227
| +23% | +$3.51M | 0.16% | 131 |
|
|
2022
Q4 | $14.9M | Buy |
27,048
+4,285
| +19% | +$2.27M | 0.13% | 176 |
|
|
2022
Q3 | $11.5M | Sell |
22,763
-2,979
| -12% | -$1.67M | 0.11% | 230 |
|
|
2022
Q2 | $14M | Sell |
25,742
-5,406
| -17% | -$2.98M | 0.11% | 225 |
|
|
2022
Q1 | $18.4M | Sell |
31,148
-23,858
| -43% | -$13.7M | 0.11% | 205 |
|
|
2021
Q4 | $36.7M | Buy |
55,006
+10,477
| +24% | +$6.54M | 0.19% | 101 |
|
|
2021
Q3 | $25.4M | Sell |
44,529
-6,228
| -12% | -$3.42M | 0.15% | 126 |
|
|
2021
Q2 | $25.6M | Sell |
50,757
-3,298
| -6% | -$1.56M | 0.15% | 130 |
|
|
2021
Q1 | $24.7M | Sell |
54,055
-5,697
| -10% | -$2.72M | 0.16% | 124 |
|
|
2020
Q4 | $27.8M | Buy |
59,752
+2,714
| +5% | +$1.27M | 0.17% | 97 |
|
|
2020
Q3 | $25.2M | Sell |
57,038
-1,295
| -2% | -$535K | 0.18% | 94 |
|
|
2020
Q2 | $21.1M | Sell |
58,333
-4,764
| -8% | -$1.6M | 0.16% | 111 |
|
|
2020
Q1 | $17.9M | Sell |
63,097
-2,274
| -3% | -$717K | 0.18% | 113 |
|
|
2019
Q4 | $21.2M | Sell |
65,371
-11,341
| -15% | -$3.44M | 0.16% | 132 |
|
|
2019
Q3 | $22.3M | Sell |
76,712
-13,601
| -15% | -$3.89M | 0.18% | 121 |
|
|
2019
Q2 | $26.5M | Sell |
90,313
-7,972
| -8% | -$2.2M | 0.22% | 83 |
|
|
2019
Q1 | $26.9M | Sell |
98,285
-10,357
| -10% | -$2.58M | 0.22% | 79 |
|
|
2018
Q4 | $24.3M | Sell |
108,642
-484
| -0.4% | -$114K | 0.21% | 76 |
|
|
2018
Q3 | $26.6M | Buy |
109,126
+1,340
| +1% | +$308K | 0.17% | 94 |
|
|
2018
Q2 | $22.3M | Sell |
107,786
-164,593
| -60% | -$34.9M | 0.15% | 116 |
|
|
2018
Q1 | $56.2M | Sell |
272,379
-43,082
| -14% | -$9.04M | 0.14% | 242 |
|
|
2017
Q4 | $59.9M | Buy |
315,461
+17,552
| +6% | +$3.36M | 0.14% | 225 |
|
|
2017
Q3 | $56.4M | Sell |
297,909
-34,422
| -10% | -$6.23M | 0.13% | 225 |
|
|
2017
Q2 | $58M | Buy |
332,331
+9,065
| +3% | +$1.52M | 0.15% | 196 |
|
|
2017
Q1 | $49.7M | Sell |
323,266
-19,154
| -6% | -$2.93M | 0.13% | 283 |
|
|
2016
Q4 | $48.3M | Buy |
342,420
+34,765
| +11% | +$5.13M | 0.14% | 246 |
|
|
2016
Q3 | $48.9M | Buy |
307,655
+35,107
| +13% | +$5.41M | 0.15% | 178 |
|
|
2016
Q2 | $40.3M | Sell |
272,548
-17,000
| -6% | -$2.51M | 0.13% | 261 |
|
|
2016
Q1 | $41M | Sell |
289,548
-39,754
| -12% | -$5.33M | 0.13% | 238 |
|
|
2015
Q4 | $46.7M | Sell |
329,302
-154,763
| -32% | -$20.6M | 0.14% | 213 |
|
|
2015
Q3 | $59.2M | Sell |
484,065
-81,902
| -14% | -$10.7M | 0.18% | 95 |
|
|
2015
Q2 | $73.4M | Buy |
565,967
+64,363
| +13% | +$8.39M | 0.18% | 90 |
|
|
2015
Q1 | $67.4M | Buy |
501,604
+83,156
| +20% | +$10.7M | 0.16% | 129 |
|
|
2014
Q4 | $52.4M | Buy |
418,448
+54,624
| +15% | +$6.64M | 0.13% | 199 |
|
|
2014
Q3 | $44.3M | Buy |
363,824
+40,616
| +13% | +$4.94M | 0.11% | 255 |
|
|
2014
Q2 | $38.1M | Buy |
323,208
+33,871
| +12% | +$3.99M | 0.1% | 326 |
|
|
2014
Q1 | $34.8M | Buy |
289,337
+14,358
| +5% | +$1.71M | 0.1% | 299 |
|
|
2013
Q4 | $30.6M | Buy |
274,979
+74,108
| +37% | +$7.37M | 0.09% | 317 |
|
|
2013
Q3 | $18.5M | Sell |
200,871
-7,782
| -4% | -$704K | 0.07% | 503 |
|
|
2013
Q2 | $17.7M | Buy |
+208,653
| New | +$17.4M | 0.07% | 400 |
|
Other funds holding TMO
VCM
Guggenheim Capital's TMO Position: Q1 2026 in Review
Guggenheim Capital reduced its Thermo Fisher Scientific (TMO) stake by 7.4% in Q1 2026, selling an estimated $1.62M and leaving 37,348 shares worth $18.4M. The position accounts for 0.14% of the portfolio, ranked #144.
Guggenheim Capital first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $73.4M in Q2 2015. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Guggenheim Capital held 37,348 shares of Thermo Fisher Scientific worth $18.4M as of Q1 2026.
- Guggenheim Capital sold 2,981 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.62M.
- Thermo Fisher Scientific made up 0.14% of Guggenheim Capital's portfolio in Q1 2026, its #144 holding.
- Guggenheim Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Guggenheim Capital's Thermo Fisher Scientific position peaked at $73.4M in Q2 2015.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.